Paklitaksel Alan Meme Kanserli Kadınlarda Rahatsız Edici Semptomlar Teorisi'ne Dayalı Yapılan Yürüyüş Egzersizinin Periferal Nöropati ve Artralji-Miyalji Üzerine Etkisi: Randomize Kontrollü Pilot Uygulama Çalışma Protokolü

Yıl 2025, Cilt: 5 Sayı: 3, 182 - 194, 29.12.2025

Deniz Özdemir , Selda Arslan

Öz

Amaç: Paklitaksel alan meme kanserli kadınlarda Rahatsız Edici Semptomlar Teorisi'ne dayalı yapılan yürüyüş egzersizinin periferal nöropati ve artralji-miyalji üzerine etkisini belirlemek amacıyla gerçekleştirilmiştir.
Gereç ve Yöntem: Araştırma, bir hastanesinin tıbbi onkoloji polikliniğinin ayaktan tedavi ünitesinde Temmuz 2022- Temmuz 2023 tarihleri arasında gerçekleştirilmiştir. Prospektif, tek kör, paralel grup randomize kontrollü tasarım olarak yapılmıştır. Örnekleme, blok randomizasyon yöntemi kullanılarak müdahale, kontrol grubu olmak üzere toplam 82 hasta dahil edilmiştir. Müdahale grubuna Rahatsız Edici Semptomlar Teorisi’ne göre fiziksel aktivitenin yararları konusunda bilgilendirmeler yapılmış, pedometreler verilmiş, günde ortalama 30 dakika yürümeleri ve adım sayılarını kaydetmeleri istenmiştir. Kontrol grubuna herhangi bir girişim yapılmamıştır. Veri toplama aracı olarak, Bilgi Formu, Kemoterapiye Bağlı Periferal Nöropati Değerlendirme Aracı ve McGill Ağrı Ölçeği Kısa Formu kullanılmıştır. Başlangıç, 4.8. ve 12. Haftalarda ölçekler uygulanmıştır. Çalışmaya katılan hastaların periferal nöropati ve artralji-miyaljiyi semptomları değerlendirilmiştir.Verilerin analizinde sayı, yüzde, ortalama, standart sapma, medyan, minimum, maksimum ve kategorik değişkenler için Pearson kikare/Fisher exact test, gruplar arası karşılaştırmada bağımsız gruplarda t testi, tekrarlı ölçümlerde ANOVA, grup-zaman etkileşimini değerlendirmek için karışık düzen ANOVA kullanılmıştır. Anlamlılık düzeyi p˂0,05 olarak kabul edilmiştir. Raporlamada CONSORT 2022 kullanılmıştır.
Sonuç: Çalışma yürüyüş egzersizinin paklitaksel alan meme kanserli kadınlarda rahatsız edici semptomlardan periferal nöropati ve artralji-miyaljiyi azaltmada yararlı olabileceği öngörülmüştür.

Anahtar Kelimeler

Periferal nöropati , Artrajji-miyalji , Yürüyüş egzersizi , Rahatsız edici semptomlar teorisi , Meme kanseri

The Effect of Walking Exercise Based on The Theory of Disturbing Symptoms in Women with Breast Cancer Receiving Paclitaxel on Peripheral Neuropathy and Arthralgia-Myalgia: Randomized Control Pilot Study Protocol

Öz

Aim: This study was conducted to determine the effect of walking exercise based on the Theory of Disturbing Symptoms on peripheral neuropathy and arthralgia-myalgia in women with breast cancer receiving paclitaxel.
Materials and Methods: The study was conducted in the outpatient unit of the medical oncology outpatient clinic of a hospital between July 2022 and July 2023. It was conducted as a prospective, single-blind, parallel group randomized controlled design. A total of 82 patients were included in the sample as intervention and control groups using the block randomization method. The intervention group was informed about the benefits of physical activity according to the Disturbing Symptoms Theory, given pedometers, and asked to walk for an average of 30 minutes a day and record the number of steps. No intervention was performed in the control group. Information Form, Chemotherapy Induced Peripheral Neuropathy Assessment Tool and McGill Pain Scale short form were used as data collection tools. The scales were administered at baseline, weeks 4, 8 and 12. Symptoms of peripheral neuropathy and arthralgia-myalgia were evaluated. Number, percentage, mean, standard deviation, median, minimum, maximum, and Pearson chi-square/Fisher exact test for categorical variables, t test in independent groups for intergroup comparison, ANOVA for repeated measures, and mixed-order ANOVA to evaluate group-time interaction were used in the analysis of the data. Significance level was accepted as p˂0.05. CONSORT 2022 was used for reporting.
Conclusion: The study suggests that walking exercise may be beneficial in reducing the uncomfortable symptoms of peripheral neuropathy and arthralgia-myalgia in women with breast cancer receiving paclitaxel.

Anahtar Kelimeler

Arthraggia-myalgia , Chemotherapy-induced peripheral neuropathy , Breast cancer , Disturbing symptoms theory , Walking exercise

Kaynakça

• 1 Akın, B., & Koçoğlu-Tanyer, D. (2021). SPIRIT 2013 Bildirisi: Klinik Deneyler İçin Standart Protokol Maddelerinin Tanımlanması. HUHEMFAD, 8(1):117-2.
• 2 Arslan, S., Bahceli, P. Z., İlik, Y., & Artaç, M. (2020). The preliminary effects of henna on chemotherapy-induced peripheral neuropathy in women receiving oxaliplatin-based treatment: A parallel-group, randomized, controlled pilot trial. European Journal of Oncology Nursing, 48, 101827. doi: 10.1016/j.ejon.2020.101827.
• 3 Asthana, R., Zhang, L., Wan, B. A., Gallo-Hershberg, D., Giotis, A., Pasetka, M., … E, De Angelis, C. (2020). Pain descriptors of taxane acute pain syndrome (TAPS) in breast cancer patients-a prospective clinical study. Support Care Cancer. Feb;28(2):589-598. doi: 10.1007/s00520-019-04845-7.
• 4 Avcı, E. E., Akgün, İ., Öztürk, O., & Özer, A. Y. (2021). Açık Alan Spor Parkı Kullanan Bireylerin Profilinin, Alışkanlıklarının ve İhtiyaçlarının Belirlenmesi: İstanbul İli Örneği. Genel Sağlık Bilimleri Dergisi, 3(2), 112-123.
• 5 Bandla, A., Tan, S., Kumarakulasinghe, N. B., Huang, Y., Ang, S., Magarajah, G., … Sundar, R. (2020). Safety and tolerability of cryocompression as a method of enhanced limb hypothermia to reduce taxane-induced peripheral neuropathy. Support Care Cancer. Aug;28(8):3691-3699. doi:10.1007/s00520-19-05177-2.
• 6 Bao, T., Zhi, I., Baser, R., Hooper, M., Chen, C., Piulson, L., …, Mao, J.J. (2020). Yoga for Chemotherapy-Induced Peripheral Neuropathy and Fall Risk: A Randomized Controlled Trial. JNCI Cancer Spectr. Jun 4;4(6):pkaa048. doi:10.1093/jncics/pkaa048.
• 7 Beijers, A. J. M., Bonhof, C. S., Mols, F., Ophorst, J., de Vos-Geelen, J., Jacobs, E. M. G., …Vreugdenhil, G. (2020). Multicenter randomized controlled trial to evaluate the efficacy and tolerability of frozen gloves for the prevention of chemotherapy-induced peripheral neuropathy. Ann Oncol. 31:131-136. doi:10.1016/j.annonc.2019.09.006.
• 8 Biçici, B. (2010). Mcgill ağrı ölçeği kısa formu’nun geçerlik ve güvenirliğinin incelenmesi. Sağlık Bilimleri Enstitüsü, Hemşirelik Esasları Anabilim Dalı, (Publication No. 301376) [İzmir: Ege Üniversitesi.]. Yök Tez&Yüksek Lisans Tezi. https://tez.yok.gov.tr/UlusalTezMerkezi/tezSorguSonucYeni.jsp.
• 9 Bland K. A., Kirkham A. A., Bovard, J., Shenkier, T., Zucker, D., McKenzie, D. C., … Campbell, K. L. (2019). Effect of exercise on taxane chemotherapy–induced peripheral neuropathy in women with breast cancer: a randomized controlled trial. Clinical breast cancer, 19, 6, 411-22. doi:10.1016/j.clbc.2019.05.013.
• 10 Bonetti, L., Tolotti, A., Anderson, G., Nania, T., Vignaduzzo, C., Sari, D., & Barello S. (2022). Nursing interventions to promote patient engagement in cancer care: A systematic review. International Journal of Nursing Studies. May;133:104289. doi:10.1016/j.nurstu.2022. 104289.
• 11 Borg, G. A. (1982) Psychophysical Bases of Perceived Exertion. Medicine & Science in Sports & Exercise, 14, 377-381. doi:10.1249/00005768-198205000-00012.
• 12 Butcher, N. J., Monsour, A., Mew, E. J., Chan, A. W., Moher, D., Mayo-Wilson E., … Offringa, M. (2022). Guidelines for Reporting Outcomes in Trial Reports: The CONSORT-Outcomes 2022 Extension. JAMA. Dec 13;328(22):2252-2264. doi:10.1001/jama.2022.21022.
• 13 Can, S. (2019). Sedentary Behavior, Number of Steps and Health. Spor Hekimliği Dergisi, 54(1):71-82. doi:10.5152/tjsm.2019.118.
• 14 Chiu, N., Chiu, L., Chow, R., Lam, H., Verma, S., Pasetka, M., … De Angelis, C. (2017). Taxane-induced arthralgia and myalgia: a literature review. Journal of Oncology Pharmacy Practice; 23(1),56-67. doi:10.1177/1078155215627502.
• 15 Chen, M. L., & Tseng, H. H. (2005). Identification and verification of symptom clusters in cancer patients. Journal of Supportive Oncology, 3(6), 28–29.
• 16 Gift, A. G., Jablonski, A., Stommel, M., & Given, C. W. (2004). Symptom clusters in elderly patients with lung cancer. Oncology Nursing Forum, 31(2), 202–212.
• 17 Derksen, T. M. E., Bours, M. J. L., Mols, F., & Weijenberg, M. P. (2017). Lifestyle Related Factors in the Self-Management of Chemotherapy-Induced Peripheral Neuropathy in Colorectal Cancer: A Systematic Review. Evidence-based Complementary and Alternative Medicine. Hindawi Limited. doi:10.1155/2017/7916031.
• 18 Dobson, J. L., McMillan, J., & Li, L. (2014). Benefits of exercise intervention in reducing neuropathic pain. Front Cell Neurosci; 8:1-9. doi:10.3389/fncel.2014.00102.
• 19 Duregon, F., Vendramin, B., Bullo, V., Gobbo, S., Cugusi, L., Di Blasio, A., … Ermolao, A. (2018). Effects of exercise on cancer patients suffering chemotherapy-induced peripheral neuropathy undergoing treatment: A systematic review. Crit Rev Oncol Hematol. (1)121:90-100. doi:10.1016/j.critrevonc.2017.11.002.
• 20 Fallon, M. T., Storey, D. J., Krishan, A., Weir, C. J., Mitchell, R., Fleetwood-Walker, S.M., … Colvin, L. A. (2015). Cancer treatment-related neuropathic pain: proof of concept study with menthol--a TRPM8 agonist. Support Care Cancer. 23(9):2769-77. doi:10.1007/s00520-015-2642-8.
• 21 Han, X., Wang, L., Shi, H., Zheng, G., He, J., Wu, W., … Cai, Z. (2017).Acupuncture combined with methylcobalamin for the treatment of chemotherapy-induced peripheral neuropathy in patients with multiple myeloma. BMC Cancer. 17, 40. doi:10.1186/s12885-016-3037-z.
• 22 Hao, J., Zhu, X., & Bensoussan, A. (2020). Effects of Nonpharmacological Interventions in Chemotherapy-Induced Peripheral Neuropathy: An Overview of Systematic Reviews and Meta-Analyses. Integr Cancer Ther. 19:1534735420945027. doi:10.1177/1534735420945027.
• 23 Hellerstedt-Börjesson, S., Nordin, K., Fjällskog, M.L., Peterson, M., & Arving, C. (2021). Taxane-induced pain in breast cancer patients as perceived by nurses. Acta Oncologica, 60(4), 412-418. doi:10.1080/0284186X.2021.1881816.
• 24 Izgu, N., Metin, Z. G., Karadas, C., Ozdemir, L., Çetin, N., & Demirci, U. (2019). Prevention of chemotherapy-induced peripheral neuropathy with classical massage in breast cancer patients receiving paclitaxel: an assessor-blinded randomized controlled trial. Eur. J. Oncol. Nurs. 40,36–43. doi:10.1016/j.ejon.2019.03.002.
• 25 Jordan, B., Jahn, F., Sauer, S., & Jordan, K. (2019). Prevention and Management of Chemotherapy-Induced Polyneuropathy. Breast Care 14(2):79-84. doi:10.1159/000499599.
• 26 Jordan, B., Margulies, A., Cardoso, F., Cavaletti, G., Haugnes, H.S., Jahn, P., … Jordan, K. (2020). Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO-EONS-EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up. Ann Oncol. Oct;31(10):1306-1319. doi:10.1016/j.annonc.2020.07.003.
• 27 Kanık, E. A., Taşdelen, B., & Erdoğan, S. (2011). Klinik denemelerde randomizasyon. Marmara Medical Journal.24(1):149-55. doi:10.5472/MMJ.2011.01981.1
• 28 Kanzawa-Lee, G. A., Knoerl, R., Donohoe, C., Bridges, C.M., & Smith, E. M. L. (2019). Mechanisms, Predictors, and Challenges in Assessing and Managing Painful Chemotherapy-Induced Peripheral Neuropathy. Semin Oncol Nurs. Jun;35(3):253-260. doi:10.1016/j.soncn.2019.04.006.
• 29 Kanzawa-Lee, G. A. (2020). Chemotherapy-Induced Peripheral Neuropathy: Nursing Implications. J Infus Nurs, 43(3),155-166. doi: 10.1097/NAN.0000000000000368.
• 30 Kanzawa-Lee, G. A., Ploutz-Snyder, R. J., Larson, J. L., Krauss, J. C., Resnicow, K., & Lavoie Smith, E., M. (2022). Efficacy of the Motivational Interviewing-Walk Intervention for Chemotherapy-Induced Peripheral Neuropathy and Quality of Life During Oxaliplatin Treatment: A Pilot Randomized Controlled Trial. Cancer Nurs. Mar-Apr 01;45(2):E531-E544. doi:10.1097/NCC.0000000000001003.
• 31 Kleckner, I.R., Kamen, C., Gewandter, J. S., Mohile, N. A., Heckler, C. E., Culakova, E., … Mustian K. M. (2018). Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: A multicenter, randomized controlled trial. Support Care Cancer. 26:1019–1028. doi:10.1007/s00520-017-4013-0.
• 32 Kurt, S., & Can, G. (2018). Reflexology in the management of chemotherapy induced peripheral neuropathy: A pilot randomized controlled trial. Eur J Oncol Nurs. Feb;32:12-19. doi: 10.1016/j.ejon.2017.11.001.
• 33 Kutlutürkan, S., Öztürk, E. S., Arıkan, F., Kahraman, B. B., Özcan, K., & Uçar, M. A. (2017). The psychometric properties of the Turkish version of the chemotherapy-induced peripheral neuropathy assessment tool (CIPNAT). European Journal of Oncology Nursing, 31,84-89. doi:10.1016/j.ejon.2017.10.001.
• 34 Lenz, E.R., Pugh, L.C., Milligan, R., Gift, A., & Suppe, F. (1997). The middle-range theory of unpleasant symptoms: An update. Adv Nurs Sci. 19(3):14-27. doi:10.1097/00012272-199703000-00003.
• 35 Lenz, E.R., Gift, A., Pugh, L., & Milligan, R.A. (2013). Theory of unpleasant symptoms. In: Peternon, SJ, Bredow T.S. (Eds). Middlerange theories: application to nursing research. (pp68-81). New York: Wolters Kluwer.
• 36 Lu, W., Giobbie-Hurder, A., Freedman, R. A., Shin, I. H., Lin, N. U., Partridge, A. H., Rosenthal, D. S., & Ligibel, J. A. (2020). Acupuncture for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Survivors: A Randomized Controlled Pilot Trial. The oncologist, 25(4),310–318. doi:10.1634/theoncologist.2019-0489.
• 37 Loprinzi, C. L., Lacchetti, C., Bleeker, J., Cavaletti, G., Chauhan, C., Hertz D. L., … Hersman Ş. L. (2020). Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update. J Clin Oncol. 38(28):3325-3348. doi:10. 1200/JCO.20.01399.
• 38 Lopez-Garzon, M., Cantarero-Villanueva, I., Postigo-Martin, P., González-Santos, Á., Lozano-Lozano, M., & Galiano-Castillo, N. (2022). Can physical exercise prevent chemotherapy-induced peripheral neuropathy in patients with cancer? A systematic review and meta-analysis. Archives of Physical Medicine and Rehabilitation. 103(11):2197-2208. doi: 10.1016/j.apmr.2022.02.008
• 39 Lopes-Júnior, L. C., Bomfim, E. O., Nascimento, L. C., Pereira, G. S., & Lima R. A .G. (2015). Teoria dos sintomas desagradáveis: subsídios para o manejo de sintomas em crianças e adolescentes oncológicos [Theory of unpleasant symptoms: support for the management of symptoms in children and adolescents with cancer]. Rev Gaucha Enferm. Sep;36(3):109-12. Portuguese. doi:10.1590/1983 1447.2015.03.51465.
• 40 Mazilu, L., Stănculeanu, D. L., Gheorghe, A. D., Voinea, F., Suceveanu, A. P., Pıțuru, S. & Suceveanu, A. I. (2019). Incidence of chemotherapy-induced peripheral neuropathy in cancer patients in clinical practice. Age, 57(13.21), 60-68. doi:10.31925/farmacia.2019.3.14
• 41 Melzack, R.(1987). The short-form McGill pain questionnaire. Pain, 30:191–197. doi:10.1016/0304-3959(87)91074-8.
• 42 Ruddy, K.J., Le-Rademacher, J., Lacouture, M.E., Wilkinson, M., Onitilo, A.A., Vander, Woude, A.C., … Loprinzi, C.L. (2019). Randomized controlled trial of cryotherapy to prevent paclitaxel-induced peripheral neuropathy; an ACCRU trial. Breast. Dec;48:89-97. doi:10.1016/j.breast.2019.09.011.
• 43 Park, R., & Park, C. (2015). Comparison of foot bathing and foot massage in chemotherapy-induced peripheral neuropathy. Cancer Nurs.38(3):239-47. doi:10.1097/NCC.0000000000000181.
• 44 Pereira, S., Fontes, F., Sonin, T., Dias, T., Fragoso, M., Castro-Lopes, J. M., & Lunet, N. (2016). Chemotherapy-induced peripheral neuropathy after neoadjuvant or adjuvant treatment of breast cancer: a prospective cohort study. Supportive Care in Cancer,24(4), 1571-1581.doi:10.1007/s00520-015-2935-y.
• 45 Sağlık Bakanlığı. (2011). Hemşirelik yönetmeliğinde değişiklik yapılmasına dair yönetmelik https://www.resmigazete.gov.tr/eskiler/2011/04/20110419-5.htm.
• 46 Schmitz, K. H., Campbell, A. M., Stuiver, M. M., Pinto, B. M., Schwartz, A.L., Morris, G. S, …. Matthews, C.E. (2019). Exercise is medicine in oncology: Engaging clinicians to help patients move through cancer. CA Cancer J Clin. 69(6):468-484. doi:10.3322/caac.21579.
• 47 Suresh, K., & Chandrashekara, S. (2012). Sample size estimation and power analysis for clinical research studies. Journal of Human Reproductive Sciences. 5(1):7. doi:10.4103/0974-1208.97779.
• 48 Tanay, M. A. L, Armes, J., Moss-Morris, R., Rafferty, A. M., & Robert G. A. (2023). Systematic review of behavioural and exercise interventions for the prevention and management of chemotherapy-induced peripheral neuropathy symptoms. J Cancer Surviv. 17(1):254-277. doi:10.1007/s11764-021-00997-w.
• 49 Tofthagen, C. S., McMillan, S. C., & Kip, K. E. (2011). Development and psychometric evaluation of the chemotherapy-induced peripheral neuropathy assessment tool. Cancer Nursing, 34(4),10-20. doi:10.1097/NCC.0b013e31820251de.
• 50 Tofthagen, C. S., Cheville, A. L., & Loprinzi, C. L. (2020). The Physical Consequences of Chemotherapy-Induced Peripheral Neuropathy. Curr Oncol Rep. Apr 22;22(5):50. doi:10.1007/s11912-020-00903-0. 51 West, H. J., & Jin, J. O. (2015). Performance status in patients with cancer. JAMA Oncology, 1(7), 998-998. doi:10.1001/jamaoncol.2015.3113.
• 52 Zajaczkowska, R., Kocot-Kepska, M., Leppert, W., Wrzosek, A., Mika, J., & Wordliczek, J. (2019). Mechanisms of Chemotherapy-Induced Peripheral Neuropathy. International Journal of Molecular Sciences. 20(6):1451. doi:10.3390/ms20061451.
• 53 Zimmer, P., Trebing, S., Timmers-Trebing, U., Schenk, A., Paust, R., Bloch, W., … Baumann, F.T. (2018). Eight-week, multimodal exercise counteracts a progress of chemotherapy-induced peripheral neuropathy and improves balance and strength in metastasized colorectal cancer patients: a randomized controlled trial. Support Care Cancer. 26(2):615-624. doi:10.1007/s00520-017-3875-5.